To generalize the antileukemic activity of ARV-825, we further extended the in vivo study on a human CUL76 PDX (CDKN2A/B mut, Notch1 HD /PEST mut) model of T-ALL. Here, CDKN2A is linked to acute lymphoblastic leukemia.